COVID-19 Vaccine Facts
Drug Company Clinical Trial Numbers are Unreliable
The drug companies conducted very short-term research on their COVID-19 vaccine drugs. The numbers related to adverse effects have already been shown by
independent researchers to be wildly inaccurate. Below are two examples:
- Both the Pfizer and Moderna pre-approval research claimed no cases of anaphylaxis (potentially life-threatening allergic reaction). Once the COVID-19 vaccine drugs
were given out more widely, anaphylaxis began to be reported. However, the CDC claimed it was
etremely rare. Subsequently, research on 52,805 subjects showed that
anaphylaxis reactions occurred 50 to 100 times more frequently than claimed by the CDC. The moral of this story is that you will almost never see serious reactions
in drug company-sponsored research and that the CDC will tend to downplay serious reactions by 50 to 100 times or more.
- It is likely far too early to determine the effects of COVID-19 vaccine drugs on pregnant woman. But the
supplemental appendix of one such study provides
useful data of serious adverse reactions to COVID-19 vaccine drugs that can be compared to the drug company research. Table S3 provide the percentages of
pregant and non-pregnant women experiencing a short-term, serious reaction to the COVID-19 vaccine drugs as reported by the CDC's "v-safe" monitoring program. Keep in
mind that the values below for v-safe are only for adverse reactions on the day after the vaccination while the values in the Pfizer and Moderna research are for a full
seven days.
Serious short-term adverse effects following dose 2 of the COVID-19 vaccine drugs (7 days for Pfizer & Moderna; 1 day for v-safe)
| Adverse Effect
| % v-safe
| % Pfizer
| % Moderna
|
| Joint Pain |
7.6% |
0.4% |
5.9% |
| Myaglia |
13.6% |
1.0% |
10.1% |
| Fatigue |
14.6% |
0.7% |
10.7% |